FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4067211000001102: Posalfilin ointment (Norgine Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17872101000001114 Posalfilin ointment (Norgine Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38339001000001112 Posalfilin ointment (Norgine Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Posalfilin ointment (Norgine Ltd) Is a Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has active ingredient Podophyllin false Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has active ingredient Keratolytic agent false Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has active ingredient Podophyllum resin false Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Is a Posalfilin true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has specific active ingredient Podophyllum resin true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Posalfilin ointment (Norgine Ltd) 10 gram Is pack of False Posalfilin ointment (Norgine Ltd) Inferred relationship Existential restriction modifier
Posalfilin ointment (Norgine Ltd) 10 gram Has AMP True Posalfilin ointment (Norgine Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start